Zdravniški Vestnik (Jun 2018)

Position statement of the Slovenian society of anaesthesiology and intensive care medicine on the use of sugammadex

  • Neva Požar Lukanović,
  • Dragan Dević,
  • Rajko Kandare,
  • Dušan Mekiš,
  • Vesna Novak Janković,
  • Barbka Novak Supe,
  • Ana Pekle Golež,
  • Alenka Spindler Vesel

DOI
https://doi.org/10.6016/ZdravVestn.2624
Journal volume & issue
Vol. 87, no. 5-6

Abstract

Read online

We present our position statement for the use of sugammadex, a specific binder for aminosteroid muscle relaxants, in the most common clinical circumstances (in the case of an emergency intubation, when the patient cannot be ventilated or intubated; in patients with neuro-muscular disease, in patients with liver failure, in patients with renal failure, in patients with allergic reaction to sugammadex or to rocuronium, in cases of residual muscle relaxation and when we have to use a muscle relaxant short time after sugammadex application). Sugammadex is the drug of choice in cases of cardiac arhythmia, COPD, asthma, neuro-muscular diseases, pathological obesity, intraoperative use of continuous infusion of aminoglycoside muscle relaxants. It is therefore necessary to control the neuro-muscular block during surgery due to different response of patients to the muscle relaxant. Clinical tests alone are not an adequate substitute for objective control of muscular strength recovery.

Keywords